మా గ్రూప్ ప్రతి సంవత్సరం USA, యూరప్ & ఆసియా అంతటా 3000+ గ్లోబల్ కాన్ఫరెన్స్ ఈవెంట్లను నిర్వహిస్తుంది మరియు 1000 కంటే ఎక్కువ సైంటిఫిక్ సొసైటీల మద్దతుతో 700+ ఓపెన్ యాక్సెస్ జర్నల్లను ప్రచురిస్తుంది , ఇందులో 50000 మంది ప్రముఖ వ్యక్తులు, ప్రఖ్యాత శాస్త్రవేత్తలు ఎడిటోరియల్ బోర్డ్ సభ్యులుగా ఉన్నారు.
ఎక్కువ మంది పాఠకులు మరియు అనులేఖనాలను పొందే ఓపెన్ యాక్సెస్ జర్నల్స్
700 జర్నల్స్ మరియు 15,000,000 రీడర్లు ప్రతి జర్నల్ 25,000+ రీడర్లను పొందుతున్నారు
Ene AC, Aniche CB, Ajuzieogu GI, Elezua VC, Ezeifeka FC
The acute toxicity of aqueous leaf extract of Newbouldia laevis was evaluated in Swiss albino mice. For the first phase, the mice were divided into four groups of three animals each at random. The aqueous leaf extract of Newbouldia laevis was administered both orally and intraperitoneally to the groups in doses of 0, 10, 100, and 1000 mg/kg body weight, respectively. The animals were separated into four groups of three animals each for the second phase of administration, and single doses of the extract at 0, 1600, 2900, and 5000 mg/kg body weight were administered. Animals in both phases were closely monitored for 24 hours and 14 days, respectively. For the animals that got the extract through the oral route, no death was recorded in any of the groups in both phase. The LD50 of the aqueous leaf extract of Newbouldia laevis when administered orally was calculated to be up to 5000 mg/kg. The results indicate that the extract may be safe to be used at high doses through the oral route. For the intraperitoneal administration, no death was recorded in any of the groups in phase I, however, all the animals that got the extract in phase II died within 24 hours after intraperitoneal administration. The LD50 of the aqueous leaf extract of Newbouldia laevis when administered intraperitoneally was calculated to be 1264.9 mg/kg. The results indicate that the extract may be toxic at a high dose in short-term exposure and non-toxic when taken at low doses through the intraperitoneal route.